Analysis Reports on Active NASDAQ Stocks: (NASDAQ:ATHX), (NASDAQ:PDLI)
Athersys, Inc. (NASDAQ:ATHX) announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has approved Athersys' application to expand its ongoing Phase 2 study evaluating the administration of MultiStem(R) therapy to patients who have suffered an ischemic stroke.
View full press release